AllianceBernstein’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,000
Closed -$46.3K 3322
2024
Q1
$46.3K Hold
18,000
﹤0.01% 3096
2023
Q4
$36.7K Hold
18,000
﹤0.01% 3153
2023
Q3
$31K Hold
18,000
﹤0.01% 3161
2023
Q2
$35.1K Buy
+18,000
New +$42.1K ﹤0.01% 3146
2022
Q2
Sell
-42,200
Closed -$174K 3410
2022
Q1
$174K Buy
42,200
+100
+0.2% +$530 ﹤0.01% 3019
2021
Q4
$541K Buy
42,100
+9,100
+28% +$101K ﹤0.01% 2708
2021
Q3
$356K Hold
33,000
﹤0.01% 2901
2021
Q2
$301K Buy
33,000
+8,600
+35% +$79.5K ﹤0.01% 3006
2021
Q1
$230K Sell
24,400
-16,400
-40% -$226K ﹤0.01% 3009
2020
Q4
$161K Hold
40,800
﹤0.01% 3043
2020
Q3
$108K Sell
40,800
-4,000
-9% -$14.8K ﹤0.01% 3067
2020
Q2
$297K Buy
44,800
+18,400
+70% +$124K ﹤0.01% 2877
2020
Q1
$154K Buy
26,400
+7,800
+42% +$65.5K ﹤0.01% 2864
2019
Q4
$167K Hold
18,600
﹤0.01% 2959
2019
Q3
$161K Buy
18,600
+5,500
+42% +$55.6K ﹤0.01% 2991
2019
Q2
$146K Buy
+13,100
New +$150K ﹤0.01% 3024
2018
Q4
Sell
-20,000
Closed -$285K 3156
2018
Q3
$285K Buy
+20,000
New +$285K ﹤0.01% 2870

Other funds holding GRTS

AllianceBernstein's GRTS Position: Q2 2024 in Review

AllianceBernstein sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 18,000 shares — an estimated $46.3K sold.

AllianceBernstein first reported a position in GRTS in Q3 2018 and held it in 17 quarters. The position peaked at $541K in Q4 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • AllianceBernstein reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • AllianceBernstein sold 18,000 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $46.3K.
  • AllianceBernstein first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 17 quarters.
  • AllianceBernstein's Gritstone bio, Inc. Common Stock position peaked at $541K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.